Ensysce Biosciences Corrects Series B Preferred Stock Designation
at www.tipranks.com (Mon, 23-Mar 8:30 AM)
Ensysce Biosciences Targets Regulatory Risk With Strategic AMA Session as PF614 Program Gains Focus
Market Chameleon (Thu, 5-Mar 11:08 AM)
ENSC Initiates Strategic Review—Could New Partnerships Unlock Value for Shareholders?
Market Chameleon (Fri, 27-Feb 9:51 AM)
